How Is The Porcine Epidemic Diarrhea Vaccines Market Expected To Grow At 7.1% CAGR Over 2025–2029?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Projected Valuation Of The Porcine Epidemic Diarrhea Vaccines Market In The Coming Years?
In recent times, there has been a significant expansion in the market size of porcine epidemic diarrhea vaccines. The market is projected to increase from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The considerable growth noted during the historic period can be credited to extensive vaccination campaigns, the enlargement of immunization programs, the utilization of one-time usage syringes, endeavor to eliminate diarrhea, and initiatives like the global alliance for vaccines and immunization (GAVI).
The market for porcine epidemic diarrhea vaccines is projected to witness notable expansion in the forthcoming years, escalating to $2.37 billion by 2029 with a compound annual growth rate (CAGR) of 7.1%. The anticipated growth throughout this period can be linked to the increasing focus on immunization initiatives, advancements in vaccine creation pathways, burgeoning pig populations, emphasis on cold chain management systems, and heightened awareness regarding the necessity of preventive health measures. The forecast period also suggests ongoing innovation in vaccine delivery equipment technology, emphasizing needle-free solutions, progression in customized medicine, a rising inclination towards self-administered vaccines, and fortification of animal healthcare infrastructure and distribution channels.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Porcine Epidemic Diarrhea Vaccines Market?
The surge in pig farming is set to fuel the expansion of the porcine epidemic diarrhea vaccine market in the future. This type of farming entails raising domestic pigs for purposes such as meat production, breeding, rearing from birth to saleable weight, and the marketing and selling of pork products. The growth in pig farming can be attributed to the increasing global demand for pork, enhanced breeding and management methods, advancements in farming technology, and the growth of markets for pork consumption. Porcine epidemic diarrhea (PED) vaccines play a crucial role in pig farming in order to control and prevent disease outbreaks, usually administered as an injection or orally from the sow’s gestation period to pass on passive immunity to newborn piglets via colostrum. For instance, data from the United States Department of Agriculture, a US-based government body, shows that in 2022, pork production in the United States came in at 40.6 billion pounds, showing a rise of 1 percent compared to the preceding year. Consequently, the surge in pig farming is playing a key role in driving the expansion of the porcine epidemic diarrhea vaccine market.
Which Segmentation Categories Are Highlighted In The Porcine Epidemic Diarrhea Vaccines Market Analysis?
The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
Which Market Trends Are Expected To Define The Future Of The Porcine Epidemic Diarrhea Vaccines Market?
Leading enterprises in the porcine epidemic diarrhea vaccines market are creating groundbreaking products like the porcine parvovirus (PPV) vaccine to solidify their market presence. The PPV vaccine is an animal-health solution aimed at curtailing reproductive issues in pigs provoked by PPV, a minor, non-encapsulated virus known for causing infertility, stillbirths, mummification of fetuses, and feeble piglets. For instance, Boehringer Ingelheim, a pharmaceutical company based in Germany, recently launched the ReproCyc ParvoFLEX PPV vaccine in March 2022. This state-of-the-art vaccine is engineered to fight reproductive problems in pigs, including infertility, stillbirths, mummified fetuses, and feeble piglets caused by PPV, a minor, non-encapsulated virus. The uniqueness of this product lies in its superior formulation and effectiveness in offering extensive protection against reproductive losses caused by PPV, thereby ensuring the health and productivity of pig populations.
Which Companies Hold A Competitive Edge In The 455 Market?
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Porcine Epidemic Diarrhea Vaccines Market?
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
